4//SEC Filing
Palaniappan Jyoti 4
Accession 0001209191-21-027852
CIK 0001478320other
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 6:00 PM ET
Size
9.0 KB
Accession
0001209191-21-027852
Insider Transaction Report
Form 4
Palaniappan Jyoti
SVP, Diagnostics, immunoSEQ Dx
Transactions
- Sale
Common Stock
2021-04-19$41.25/sh−1,301$53,666→ 9,158 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-04-19−1,301→ 107,647 totalExercise: $22.55Exp: 2030-03-19→ Common Stock (1,301 underlying) - Exercise/Conversion
Common Stock
2021-04-19$22.55/sh+1,301$29,338→ 10,459 total
Footnotes (2)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2020.
- [F2]The options vested with respect to 1/4 of such shares on March 18, 2021, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
Documents
Issuer
Adaptive Biotechnologies Corp
CIK 0001478320
Entity typeother
Related Parties
1- filerCIK 0001807021
Filing Metadata
- Form type
- 4
- Filed
- Apr 20, 8:00 PM ET
- Accepted
- Apr 21, 6:00 PM ET
- Size
- 9.0 KB